These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 2425102

  • 1. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S, Kobayashi M, Hashiba K.
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [Abstract] [Full Text] [Related]

  • 2. Role of renal kallikrein in control of renin release in conscious rats.
    Kobayashi M, Suzuki S, Hashiba K.
    Am J Physiol; 1983 Mar; 244(3):E262-5. PubMed ID: 6187220
    [Abstract] [Full Text] [Related]

  • 3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K, Yasujima M, Chiba S, Sato M, Irokawa N, Imai Y, Yoshinaga K.
    Adv Exp Med Biol; 1979 Mar; 120B():487-501. PubMed ID: 517244
    [Abstract] [Full Text] [Related]

  • 4. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y, Yamasaki K, Soejima H, Ikegami K.
    Urol Int; 1984 Mar; 39(1):52-7. PubMed ID: 6587655
    [Abstract] [Full Text] [Related]

  • 5. Renal kallikrein-kinin: its relation to renal prostaglandins and renin-angiotensin-aldosterone in man.
    Abe K, Sato M, Imai Y, Haruyama T, Sato K, Hiwatari M, Kasai Y, Yoshinaga K.
    Kidney Int; 1981 Jun; 19(6):869-80. PubMed ID: 7021957
    [No Abstract] [Full Text] [Related]

  • 6. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S, Kher V, Scicli AG, Beierwaltes WH, Carretero OA.
    Hypertension; 1983 Jun; 5(6):893-9. PubMed ID: 6197374
    [Abstract] [Full Text] [Related]

  • 7. Synergic effects of kallikrein-kinin and prostaglandins on renin release on infusion of isolated hog kidney with aldosterone.
    Gotoh S, Ogihara T, Nakamaru M, Ohde H, Higaki J, Otsuka A, Tabuchi Y, Kumahara Y, Nishino T.
    Life Sci; 1984 May 14; 34(20):1913-8. PubMed ID: 6203005
    [Abstract] [Full Text] [Related]

  • 8. Effects of prostaglandin synthesis inhibitors on the renin-angiotensin system and renal function.
    Izumi Y, Franco-Saenz R, Mulrow PJ.
    Hypertension; 1985 May 14; 7(5):791-6. PubMed ID: 3861577
    [Abstract] [Full Text] [Related]

  • 9. Participation of the prostaglandin system in furosemide-induced changes of renal function in anesthetized rats.
    Yoshida M, Suzuki-Kusaba M, Satoh S.
    Ren Physiol; 1987 May 14; 10(1):25-32. PubMed ID: 2446364
    [Abstract] [Full Text] [Related]

  • 10. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.
    Overlack A, Stumpe KO, Müller HM, Kolloch R, Higuchi M.
    Klin Wochenschr; 1982 Oct 01; 60(19):1223-8. PubMed ID: 6183482
    [Abstract] [Full Text] [Related]

  • 11. Effects of indomethacin on plasma renin activity in the conscious rat.
    Suzuki S, Franco-Saenz R, Tan SY, Mulrow PJ.
    Am J Physiol; 1981 Mar 01; 240(3):E286-9. PubMed ID: 7011052
    [Abstract] [Full Text] [Related]

  • 12. Mineralocorticoid escape during kallikrein inhibition.
    Overlack A, Bäcker-Kreutz E, Ressel C, Müller HM, Kolloch R, Stumpe KO.
    Clin Sci (Lond); 1986 Jan 01; 70(1):13-7. PubMed ID: 2417776
    [Abstract] [Full Text] [Related]

  • 13. [Furosemide interaction with the prostaglandin and kallikrein-kinin systems of the kidneys].
    Kuz'min OB, Mikhaĭlenko PV, Kriukova RA.
    Farmakol Toksikol; 1986 Jan 01; 49(2):21-4. PubMed ID: 2423364
    [Abstract] [Full Text] [Related]

  • 14. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC, Hollifield JW, Dormois JC, Frölich BL, Seyberth H, Michelakis AM, Oates JA.
    Circ Res; 1976 Sep 01; 39(3):447-52. PubMed ID: 821675
    [Abstract] [Full Text] [Related]

  • 15. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P, Oppes M, Soro A, Dessi'-Fulgheri P, Glorioso N, Bandiera F, Manunta P, Rubattu S, Rappelli A.
    J Hypertens; 1987 Oct 01; 5(5):581-6. PubMed ID: 2448367
    [Abstract] [Full Text] [Related]

  • 16. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
    Abe K, Yasujima M, Sakurai Y, Chiba S, Itoh T, Imai Y, Sato M, Haruyama T, Omata K, Goto T, Sato K, Hiwatari M, Otsuka Y, Yoshinaga K.
    Jpn Circ J; 1979 Dec 01; 43(12):1105-16. PubMed ID: 396385
    [No Abstract] [Full Text] [Related]

  • 17. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids.
    Nasjletti A, McGiff JC, Colina-Chourio J.
    Circ Res; 1978 Nov 01; 43(5):799-807. PubMed ID: 309362
    [Abstract] [Full Text] [Related]

  • 18. The effect of prostaglandin inhibition on renin release. A comparison of furosemide and low-sodium stimulation tests.
    Goldiner WH, Valente WA, Hamilton BP, Mersey JH.
    J Lab Clin Med; 1981 Dec 01; 98(6):929-37. PubMed ID: 7031155
    [Abstract] [Full Text] [Related]

  • 19. Relationship between kallikrein and PRA after intravenous furosemide.
    Cinotti GA, Stirati G, Taggi F, Ronci R, Simonetti BM, Pierucci A.
    J Endocrinol Invest; 1979 Dec 01; 2(2):147-50. PubMed ID: 489923
    [Abstract] [Full Text] [Related]

  • 20. Isolated hypoaldosteronism and abnormalities in renin, kallikrein, and prostaglandin.
    Kaufman JS, Peck M, Hamburger RJ, Flamenbaum W.
    Nephron; 1986 Dec 01; 43(3):203-10. PubMed ID: 3523269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.